LabCorp hit with further $100m in DNA test patent case
Judge Albright awards punitive damages due to the 'intentional' nature of the infringement | Ravgen fails to secure a three-fold increase on damages awarded by a US jury last year.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
4 June 2026 The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.
4 June 2026 The new recruit, who will also support the firm’s UPC practice, brings more than 25 years’ experience and a “strong track record of handling technically and legally complex disputes” in the UK.
4 June 2026 The Indian firm has added a partner who brings more than three decades of experience advising clients across the pharmaceuticals, life sciences, technology and manufacturing sectors.